JP2017512806A5 - - Google Patents

Download PDF

Info

Publication number
JP2017512806A5
JP2017512806A5 JP2016559907A JP2016559907A JP2017512806A5 JP 2017512806 A5 JP2017512806 A5 JP 2017512806A5 JP 2016559907 A JP2016559907 A JP 2016559907A JP 2016559907 A JP2016559907 A JP 2016559907A JP 2017512806 A5 JP2017512806 A5 JP 2017512806A5
Authority
JP
Japan
Prior art keywords
amino
imidazole
dicarboxamide
phenyl
fluorobenzoyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2016559907A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017512806A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/057167 external-priority patent/WO2015150449A2/en
Publication of JP2017512806A publication Critical patent/JP2017512806A/ja
Publication of JP2017512806A5 publication Critical patent/JP2017512806A5/ja
Withdrawn legal-status Critical Current

Links

JP2016559907A 2014-04-02 2015-04-01 Tnks1および/またはtnks2の阻害剤としてのアミド置換されたアゾール化合物 Withdrawn JP2017512806A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201461973925P 2014-04-02 2014-04-02
US61/973,925 2014-04-02
EP14163261 2014-04-02
EP14163261.2 2014-04-02
PCT/EP2015/057167 WO2015150449A2 (en) 2014-04-02 2015-04-01 Amido-substituted azole compounds

Publications (2)

Publication Number Publication Date
JP2017512806A JP2017512806A (ja) 2017-05-25
JP2017512806A5 true JP2017512806A5 (enExample) 2018-05-17

Family

ID=53724279

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016559907A Withdrawn JP2017512806A (ja) 2014-04-02 2015-04-01 Tnks1および/またはtnks2の阻害剤としてのアミド置換されたアゾール化合物

Country Status (25)

Country Link
US (1) US9884063B2 (enExample)
EP (1) EP3126337A2 (enExample)
JP (1) JP2017512806A (enExample)
KR (1) KR20160133001A (enExample)
CN (1) CN106459015A (enExample)
AP (1) AP2016009476A0 (enExample)
AU (1) AU2015239548A1 (enExample)
BR (1) BR112016022749A2 (enExample)
CA (1) CA2944370A1 (enExample)
CL (1) CL2016002482A1 (enExample)
CR (1) CR20160462A (enExample)
CU (1) CU20160148A7 (enExample)
DO (1) DOP2016000268A (enExample)
EA (1) EA201691962A1 (enExample)
HK (1) HK1231484A1 (enExample)
IL (1) IL247678A0 (enExample)
MA (1) MA39824A (enExample)
MX (1) MX2016012937A (enExample)
PE (1) PE20161386A1 (enExample)
PH (1) PH12016501932A1 (enExample)
SG (1) SG11201607735TA (enExample)
SV (1) SV2016005293A (enExample)
TW (1) TW201623249A (enExample)
UY (1) UY36060A (enExample)
WO (1) WO2015150449A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017055316A1 (en) 2015-10-01 2017-04-06 Bayer Pharma Aktiengesellschaft Amido-substituted azole compounds
WO2017055313A1 (en) 2015-10-01 2017-04-06 Bayer Pharma Aktiengesellschaft Amido-substituted azole compounds
TWI794171B (zh) 2016-05-11 2023-03-01 美商滬亞生物國際有限公司 Hdac抑制劑與pd-l1抑制劑之組合治療
TWI808055B (zh) 2016-05-11 2023-07-11 美商滬亞生物國際有限公司 Hdac 抑制劑與 pd-1 抑制劑之組合治療
WO2018078005A1 (en) 2016-10-29 2018-05-03 Bayer Pharma Aktiengesellschaft Amido-substituted azaspiro derivatives as tankyrase inhibitors
WO2018078009A1 (en) 2016-10-29 2018-05-03 Bayer Pharma Aktiengesellschaft Amido-substituted cyclohexane derivatives
WO2018087126A1 (en) 2016-11-09 2018-05-17 Bayer Pharma Aktiengesellschaft Amido-substituted cyclohexane derivatives as inhibitors of tankyrase

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5616489A (en) * 1979-07-20 1981-02-17 Ajinomoto Co Inc Imidazolecarboxylic acid derivative
BR0011818A (pt) 1999-06-24 2002-03-19 Nihon Nohyaku Co Ltd Derivado de diamida do ácido dicarboxìlico heterocìclico,inseticida agrìcola e hortìcola e método papa aplicar um inseticida agrìcola e hortìcola
DE102004058062A1 (de) * 2004-12-02 2006-06-08 Bayer Healthcare Ag Cyclische Iminocarbamate und ihre Verwendung
US7562189B2 (en) 2006-09-28 2009-07-14 Network Appliance, Inc. Write-in-place within a write-anywhere filesystem
CA2663856A1 (en) * 2006-09-28 2008-04-10 Exelixis, Inc. Jak-2 modulators and methods of use
AU2008324203A1 (en) 2007-11-05 2009-05-14 Novartis Ag Methods and compositions for measuring Wnt activation and for treating Wnt-related cancers
US8440710B2 (en) 2009-10-15 2013-05-14 Hoffmann-La Roche Inc. HSL inhibitors useful in the treatment of diabetes
US9725479B2 (en) 2010-04-22 2017-08-08 Ionis Pharmaceuticals, Inc. 5′-end derivatives
CN103429583A (zh) 2010-12-08 2013-12-04 奥斯陆大学医院公司 作为wnt信号通路抑制剂的三唑衍生物
US8722721B2 (en) 2011-03-16 2014-05-13 Hoffmann-La Roche Inc. SEC-hydroxycyclohexyl derivatives
US9181266B2 (en) 2011-07-13 2015-11-10 Novartis Ag 2-piperidin-1-yl-acetamide compounds for use as tankyrase inhibitors
US9227982B2 (en) 2011-07-13 2016-01-05 Novartis Ag 4-oxo-3,5,7,8-tetrahydro-4H-pyrano[4,3-d]pyrminidinyl compounds for use as tankyrase inhibitors
US9056877B2 (en) 2011-07-19 2015-06-16 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
EP2734520B1 (en) 2011-07-19 2016-09-14 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
PE20141371A1 (es) 2011-08-29 2014-10-13 Infinity Pharmaceuticals Inc Compuestos heterociclicos y usos de los mismos
WO2013093508A2 (en) 2011-12-22 2013-06-27 Oslo University Hospital Hf Wnt pathway inhibitors
EP2822944A1 (en) 2012-03-05 2015-01-14 Amgen, Inc. Oxazolidinone compounds and derivatives thereof
US8940742B2 (en) 2012-04-10 2015-01-27 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
SG11201406997WA (en) 2012-05-04 2014-11-27 Merck Patent Gmbh Pyrrolotriazinone derivatives
WO2013177349A2 (en) 2012-05-25 2013-11-28 Glaxosmithkline Llc Quinazolinediones as tankyrase inhibitors
CA2874546A1 (en) 2012-06-07 2013-12-12 F. Hoffmann-La Roche Ag Pyrazolopyrimidone and pyrazolopyridone inhibitors of tankyrase
CA2870062A1 (en) 2012-06-20 2013-12-27 F.Hoffmann-La Roche Ag Pyrrolopyrazone inhibitors of tankyrase
HK1206339A1 (en) 2012-06-20 2016-01-08 霍夫曼-拉罗奇有限公司 N-aryltriazole compounds as lpar antagonists
CN104507912B (zh) 2012-08-08 2016-09-28 默克专利股份公司 (氮杂-)异喹啉酮衍生物
KR102218510B1 (ko) 2013-05-23 2021-02-19 닛산 가가쿠 가부시키가이샤 액정 배향 처리제, 액정 배향막 및 액정 표시 소자
CN103923237B (zh) 2013-10-31 2017-01-25 北京利和知信科技有限公司 用于烯烃聚合的催化剂组分及其应用
US10100027B2 (en) 2014-09-26 2018-10-16 Changzhou Yinsheng Pharmaceutical Co., Ltd. Benzofuran analogue as NS4B inhibitor
JP2018520992A (ja) 2015-05-05 2018-08-02 バイエル ファーマ アクチエンゲゼルシャフト アミドで置換されているシクロヘキサン誘導体
WO2017055316A1 (en) 2015-10-01 2017-04-06 Bayer Pharma Aktiengesellschaft Amido-substituted azole compounds
WO2017055313A1 (en) 2015-10-01 2017-04-06 Bayer Pharma Aktiengesellschaft Amido-substituted azole compounds

Similar Documents

Publication Publication Date Title
JP5650735B2 (ja) タンパク質キナーゼ調節剤としてのピリジンおよびピラジン誘導体
WO2012101066A1 (en) Pyridine biaryl amine compounds and their uses
JP2020073538A (ja) 6−(5−ヒドロキシ−1h−ピラゾール−1−イル)ニコチンアミド誘導体およびphd阻害剤としてのそれらの使用
JP5687293B2 (ja) 酸分泌抑制薬
WO2012101065A2 (en) Pyrimidine biaryl amine compounds and their uses
WO2012101062A1 (en) Substituted bi-heteroaryl compounds as cdk9 inhibitors and their uses
TWI388551B (zh) 5,6-雙芳基-2-吡啶-甲醯胺之衍生物,其製備及其作為尿加壓素ii受體拮抗劑之治療應用
EA033686B1 (ru) Гетероциклические соединения, применимые в качестве модуляторов tnf-альфа
WO2012101064A1 (en) N-acyl pyrimidine biaryl compounds as protein kinase inhibitors
WO2015016206A1 (ja) 複素環化合物
JP2020506946A5 (enExample)
HUE033177T2 (en) Pyrazine carboxamide compound
KR20120049940A (ko) 키나제 억제제로서의 헤테로아릴 화합물
US20120165306A1 (en) Pyrazinylpyridines useful for the treatment of proliferative diseases
WO2012101063A1 (en) N-acyl pyridine biaryl compounds and their uses
JP2016535755A (ja) Gsk−3阻害剤
CN102471310A (zh) 用于治疗增生性疾病的联吡啶化合物
RU2019113764A (ru) Соединения хиноксалина в качестве ингибиторов рецепторной тирозинкиназы iii типа
AU2016317806A1 (en) Heteroaryl compounds and their use as therapeutic drugs
WO2018071343A1 (en) Heteroaryl compounds and their use as mer inhibitors
JP2019530708A5 (enExample)
CA3130245A1 (en) Heterocyclic compound, pharmaceutical composition comprising same, preparation method therefor, and use thereof
WO2016144792A1 (en) Alpha 7 nicotinic acetylcholine receptor allosteric modulators, their derivatives and uses thereof
JP2017516772A5 (enExample)